Omega-3 fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: A secondary outcome analysis of the OFFER randomized controlled study

Schizophrenia Research

Volumn 195, Issue , 2018, Pages 168-175

  Pawełczyk, Tomasz ^a   Piątkowska Janko, Ewa ^b   Bogorodzki, Piotr ^b   Gębski, Piotr ^c   Grancow Grabka, Marta ^d   Trafalska, Elżbieta ^a   Żurner, Natalia ^c   Pawełczyk, Agnieszka ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

^c MRI Department   (Poland)

^d Centralny Szpital Kliniczny UM w odzi   (Poland)

Author keywords

Antipsychotics; Docosahexaenoic acid; Eicosapentaenoic acid; Magnetic resonance imaging; Neurodegeneration; Neuroprotection; Randomized controlled trial

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; NEUROLEPTIC AGENT; OLIVE OIL; OMEGA 3 FATTY ACID;

ADD ON THERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; BRAIN SIZE; BRODMANN AREA 7; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GRAY MATTER; HUMAN; LEFT HEMISPHERE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARIETAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT DURATION; VISUAL AREA V3; WHITE MATTER; BRAIN CORTEX; DIAGNOSTIC IMAGING; DIETARY SUPPLEMENT; DRUG EFFECT; HEMISPHERIC DOMINANCE; IMAGE PROCESSING; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; YOUNG ADULT;

ADULT; ANTIPSYCHOTIC AGENTS; CEREBRAL CORTEX; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; FUNCTIONAL LATERALITY; GRAY MATTER; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 85032216639     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2017.10.013     Document Type: Article

References (52)

1. Abu-Akel, A., Shamay-Tsoory, S., Neuroanatomical and neurochemical bases of theory of mind. Neuropsychologia 49 (2011), 2971–2984, 10.1016/j.neuropsychologia.2011.07.012.
2. Ahmed, M., Cannon, D.M., Scanlon, C., Holleran, L., Schmidt, H., McFarland, J., Langan, C., McCarthy, P., Barker, G.J., Hallahan, B., McDonald, C., Progressive brain atrophy and cortical thinning in schizophrenia after commencing clozapine treatment. Neuropsychopharmacology 40 (2015), 2409–2417, 10.1038/npp.2015.90.
3. Andreasen, N.C., Liu, D., Ziebell, S., Vora, A., Ho, B.-C., Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. Am. J. Psychiatry 170 (2013), 609–615, 10.1176/appi.ajp.2013.12050674.
4. Bazan, N.G., Molina, M.F., Gordon, W.C., Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu. Rev. Nutr. 31 (2011), 321–351, 10.1146/annurev.nutr.012809.104635.
5. Begum, G., Harvey, L., Dixon, C.E., Sun, D., ER stress and effects of DHA as an ER stress inhibitor. Transl Stroke Res 4 (2013), 635–642, 10.1007/s12975-013-0282-1.
6. Benetti, S., Pettersson-Yeo, W., Hutton, C., Catani, M., Williams, S.C., Allen, P., Kambeitz-Ilankovic, L.M., McGuire, P., Mechelli, A., Elucidating neuroanatomical alterations in the at risk mental state and first episode psychosis: a combined voxel-based morphometry and voxel-based cortical thickness study. Schizophr. Res. 150 (2013), 505–511, 10.1016/j.schres.2013.08.030.
7. Berger, G.E., Wood, S.J., Wellard, R.M., Proffitt, T.M., McConchie, M., Amminger, G.P., Jackson, G.D., Velakoulis, D., Pantelis, C., McGorry, P.D., Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study. Neuropsychopharmacology 33 (2008), 2467–2473, 10.1038/sj.npp.1301628.
8. Bernal-Rusiel, J.L., Greve, D.N., Reuter, M., Fischl, B., Sabuncu, M.R., Initiative, Alzheimer's Disease Neuroimaging, Statistical analysis of longitudinal neuroimage data with linear mixed effects models. NeuroImage 66 (2013), 249–260, 10.1016/j.neuroimage.2012.10.065.
9. Bois, C., Levita, L., Ripp, I., Owens, D.C.G., Johnstone, E.C., Whalley, H.C., Lawrie, S.M., Longitudinal changes in hippocampal volume in the Edinburgh high risk study of schizophrenia. Schizophr. Res. 173 (2016), 146–151, 10.1016/j.schres.2014.12.003.
10. Burke, L., Androutsos, C., Jogia, J., Byrne, P., Frangou, S., The Maudsley early onset schizophrenia study: the effect of age of onset and illness duration on fronto-parietal gray matter. Eur. Psychiatry 23 (2008), 233–236, 10.1016/j.eurpsy.2008.03.007.
11. Calder, P.C., N-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc. Nutr. Soc. 72 (2013), 326–336, 10.1017/S0029665113001031.
12. Calder, P.C., Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim. Biophys. Acta 1851 (2015), 469–484, 10.1016/j.bbalip.2014.08.010.
13. Cieslik, E.C., Seidler, I., Laird, A.R., Fox, P.T., Eickhoff, S.B., Different involvement of subregions within dorsal premotor and medial frontal cortex for pro- and antisaccades. Neurosci. Biobehav. Rev. 68 (2016), 256–269, 10.1016/j.neubiorev.2016.05.012.
14. Cutuli, D., De Bartolo, P., Caporali, P., Laricchiuta, D., Foti, F., Ronci, M., Rossi, C., Neri, C., Spalletta, G., Caltagirone, C., Farioli-Vecchioli, S., Petrosini, L., n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice. Front. Aging Neurosci., 6, 2014, 220, 10.3389/fnagi.2014.00220.
15. Cutuli, D., Pagani, M., Caporali, P., Galbusera, A., Laricchiuta, D., Foti, F., Neri, C., Spalletta, G., Caltagirone, C., Petrosini, L., Gozzi, A., Effects of Omega-3 fatty acid supplementation on cognitive functions and neural substrates: a voxel-based morphometry study in aged mice. Front. Aging Neurosci., 8, 2016, 805, 10.3389/fnagi.2016.00038.
16. Dale, A.M., Fischl, B., Sereno, M.I., Cortical surface-based analysis. I. Segmentation and surface reconstruction. NeuroImage 9 (1999), 179–194, 10.1006/nimg.1998.0395.
17. Fusar-Poli, P., Smieskova, R., Kempton, M.J., Ho, B.C., Andreasen, N.C., Borgwardt, S., Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci. Biobehav. Rev. 37 (2013), 1680–1691, 10.1016/j.neubiorev.2013.06.001.
18. Goff, D.C., Falkai, P., Fleischhacker, W.W., Girgis, R.R., Kahn, R.M., Uchida, H., Zhao, J., LIEBERMAN, J.A., The long-term effects of antipsychotic medication on clinical course in schizophrenia. Am. J. Psychiatry, 2017 appiajp201716091016 https://doi.org/10.1176/appi.ajp.2017.16091016.
19. Hirashima, F., Parow, A.M., Stoll, A.L., Demopulos, C.M., Damico, K.E., Rohan, M.L., Eskesen, J.G., Zuo, C.S., Cohen, B.M., Renshaw, P.F., Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder. Am. J. Psychiatry 161 (2004), 1922–1924, 10.1176/ajp.161.10.1922.
20. Ho, B.-C., Andreasen, N.C., Ziebell, S., Pierson, R., Magnotta, V., Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch. Gen. Psychiatry 68 (2011), 128–137, 10.1001/archgenpsychiatry.2010.199.
21. Hýža, M., Kuhn, M., Češková E., Ustohal, L., Kašpárek, T., Hippocampal volume in first-episode schizophrenia and longitudinal course of the illness. World J. Biol. Psychiatry 17 (2016), 429–438, 10.1080/15622975.2016.1199893.
22. Jahshan, C., Wynn, J.K., Mathalon, D.H., Green, M.F., Cognitive correlates of visual neural plasticity in schizophrenia. Schizophr. Res., 2017, 10.1016/j.schres.2017.03.016.
23. Köbe, T., Witte, A.V., Schnelle, A., Lesemann, A., Fabian, S., Tesky, V.A., Pantel, J., Flöel, A., Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment. NeuroImage 131 (2016), 226–238, 10.1016/j.neuroimage.2015.09.050.
24. Liu, Q., Wu, D., Ni, N., Ren, H., Luo, C., He, C., Kang, J.-X., Wan, J.-B., Su, H., Omega-3 polyunsaturated fatty acids protect neural progenitor cells against oxidative injury. Mar. Drugs 12 (2014), 2341–2356, 10.3390/md12052341.
25. Luciano, M., Corley, J., Cox, S.R., Valdés Hernández, M.C., Craig, L.C.A., Dickie, D.A., Karama, S., McNeill, G.M., Bastin, M.E., Wardlaw, J.M., Deary, I.J., Mediterranean-type diet and brain structural change from 73 to 76 years in a Scottish cohort. Neurology 88 (2017), 449–455, 10.1212/WNL.0000000000003559.
26. McNamara, R.K., Vannest, J.J., Valentine, C.J., Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: mechanisms and implications for psychopathology. World J. Psychiatry 5 (2015), 15–34, 10.5498/wjp.v5.i1.15.
27. McNamara, R.K., Asch, R.H., Lindquist, D.M., Krikorian, R., Role of polyunsaturated fatty acids in human brain structure and function across the lifespan: an update on neuroimaging findings. Prostaglandins Leukot. Essent. Fat. Acids, 2017, 10.1016/j.plefa.2017.05.001.
28. Parks, N.A., Mazzi, C., Tapia, E., Savazzi, S., Fabiani, M., Gratton, G., Beck, D.M., The influence of posterior parietal cortex on extrastriate visual activity: a concurrent TMS and fast optical imaging study. Neuropsychologia 78 (2015), 153–158, 10.1016/j.neuropsychologia.2015.10.002.
29. Patrick, R.P., Ames, B.N., Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J. 29 (2015), 2207–2222, 10.1096/fj.14-268342.
30. Pawełczyk, T., Grancow, M., Kotlicka-Antczak, M., Trafalska, E., Gębski, P., Szemraj, J., Żurner, N., Pawełczyk, A., Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods. BMC Psychiatry, 15:1(15), 2015, 97, 10.1186/s12888-015-0473-2.
31. Pawełczyk, T., Grancow-Grabka, M., Kotlicka-Antczak, M., Trafalska, E., Pawełczyk, A., A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia. J. Psychiatr. Res. 73 (2016), 34–44, 10.1016/j.jpsychires.2015.11.013.
32. Pawełczyk, T., Grancow-Grabka, M., Trafalska, E., Szemraj, J., Pawełczyk, A., Oxidative stress reduction related to the efficacy of n-3 polyunsaturated fatty acids in first episode schizophrenia: secondary outcome analysis of the OFFER randomized trial. Prostaglandins Leukot. Essent. Fat. Acids (PLEFA) 121 (2017), 7–13, 10.1016/j.plefa.2017.05.004.
33. Peters, B.D., Duran, M., Vlieger, E.J., Majoie, C.B., den Heeten, G.J., Linszen, D.H., de Haan, L., Polyunsaturated fatty acids and brain white matter anisotropy in recent-onset schizophrenia: a preliminary study. Prostaglandins Leukot. Essent. Fat. Acids 81 (2009), 61–63, 10.1016/j.plefa.2009.04.007.
34. Peters, B.D., Machielsen, M.W.J., Hoen, W.P., Caan, M.W.A., Malhotra, A.K., Szeszko, P.R., Duran, M., Olabarriaga, S.D., de Haan, L., Polyunsaturated fatty acid concentration predicts myelin integrity in early-phase psychosis. Schizophr. Bull. 39 (2013), 830–838, 10.1093/schbul/sbs089.
35. Pu, H., Guo, Y., Zhang, W., Huang, L., Wang, G., Liou, A.K., Zhang, J., Zhang, P., Leak, R.K., Wang, Y., Chen, J., Gao, Y., Omega-3 polyunsaturated fatty acid supplementation improves neurologic recovery and attenuates white matter injury after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 33 (2013), 1474–1484, 10.1038/jcbfm.2013.108.
36. Quinn, J.F., Raman, R., Thomas, R.G., Yurko-Mauro, K., Nelson, E.B., Van Dyck, C., Galvin, J.E., Emond, J., Jack, C.R., Weiner, M., Shinto, L., Aisen, P.S., Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 304 (2010), 1903–1911, 10.1001/jama.2010.1510.
37. Reuter, M., Schmansky, N.J., Rosas, H.D., Fischl, B., Within-subject template estimation for unbiased longitudinal image analysis. NeuroImage 61 (2012), 1402–1418, 10.1016/j.neuroimage.2012.02.084.
38. Ross, R.G., Olincy, A., Harris, J.G., Radant, A., Adler, L.E., Freedman, R., Anticipatory saccades during smooth pursuit eye movements and familial transmission of schizophrenia. Biol. Psychiatry 44 (1998), 690–697.
39. Sadli, N., Ackland, M.L., De Mel, D., Sinclair, A.J., Suphioglu, C., Effects of zinc and DHA on the epigenetic regulation of human neuronal cells. Cell. Physiol. Biochem. 29 (2012), 87–98, 10.1159/000337590.
40. Sansbury, B.E., Spite, M., Resolution of acute inflammation and the role of resolvins in immunity, thrombosis, and vascular biology. Circ. Res. 119 (2016), 113–130, 10.1161/CIRCRESAHA.116.307308.
41. Serhan, C.N., Dalli, J., Colas, R.A., Winkler, J.W., Chiang, N., Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim. Biophys. Acta 1851 (2015), 397–413, 10.1016/j.bbalip.2014.08.006.
42. Seymour, K., Stein, T., Sanders, L.L.O., Guggenmos, M., Theophil, I., Sterzer, P., Altered contextual modulation of primary visual cortex responses in schizophrenia. Neuropsychopharmacology 38 (2013), 2607–2612, 10.1038/npp.2013.168.
43. Smesny, S., Milleit, B., Schaefer, M.R., Hipler, U.-C., Milleit, C., Wiegand, C., Hesse, J., Klier, C.M., Holub, M., Holzer, I., Berk, M., McGorry, P.D., Sauer, H., Amminger, G.P., Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis. Prostaglandins Leukot. Essent. Fat. Acids 101 (2015), 15–21, 10.1016/j.plefa.2015.07.001.
44. Staubo, S.C., Aakre, J.A., Vemuri, P., Syrjanen, J.A., Mielke, M.M., Geda, Y.E., Kremers, W.K., Machulda, M.M., Knopman, D.S., Petersen, R.C., Jack, C.R., Roberts, R.O., Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness. Alzheimers Dement. 13 (2017), 168–177, 10.1016/j.jalz.2016.06.2359.
45. Suphioglu, C., De Mel, D., Kumar, L., Sadli, N., Freestone, D., Michalczyk, A., Sinclair, A., Ackland, M.L., The omega-3 fatty acid, DHA, decreases neuronal cell death in association with altered zinc transport. FEBS Lett. 584 (2010), 612–618, 10.1016/j.febslet.2009.12.013.
46. Torres, U.S., Duran, F.L.S., Schaufelberger, M.S., Crippa, J.A.S., Louzã M.R., Sallet, P.C., Kanegusuku, C.Y.O., Elkis, H., Gattaz, W.F., Bassitt, D.P., Zuardi, A.W., Hallak, J.E.C., Leite, C.C., Castro, C.C., Santos, A.C., Murray, R.M., Busatto, G.F., Patterns of regional gray matter loss at different stages of schizophrenia: a multisite, cross-sectional VBM study in first-episode and chronic illness. Neuroimage Clin. 12 (2016), 1–15, 10.1016/j.nicl.2016.06.002.
47. van der Kemp, W.J.M., Klomp, D.W.J., Kahn, R.S., Luijten, P.R., Hulshoff Pol, H.E., A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia. Schizophr. Res. 141 (2012), 153–161, 10.1016/j.schres.2012.08.014.
48. van Haren, N.E.M., Cahn, W., Hulshoff Pol, H.E., Kahn, R.S., Schizophrenia as a progressive brain disease. Eur. Psychiatry Schizophrenia as a progressive brain disease (2008), 245–254, 10.1016/j.eurpsy.2007.10.013.
49. Witte, A.V., Kerti, L., Hermannstädter, H.M., Fiebach, J.B., Schreiber, S.J., Schuchardt, J.P., Hahn, A., Flöel, A., Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb. Cortex 24 (2014), 3059–3068, 10.1093/cercor/bht163.
50. Wood, S.J., Cocchi, L., Proffitt, T.-M., McConchie, M., Jackson, G.D., Takahashi, T., Pantelis, C., McGorry, P.D., Berger, G.E., Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study. Psychiatry Res. 182 (2010), 180–182, 10.1016/j.pscychresns.2009.12.003.
51. Xu, Z., Shen, X., Pan, W., Initiative, Alzheimer's Disease Neuroimaging, Longitudinal analysis is more powerful than cross-sectional analysis in detecting genetic association with neuroimaging phenotypes. PLoS One, 9, 2014, e102312, 10.1371/journal.pone.0102312.
52. Zai, G., Robbins, T.W., Sahakian, B.J., Kennedy, J.L., A review of molecular genetic studies of neurocognitive deficits in schizophrenia. Neurosci. Biobehav. Rev. 72 (2017), 50–67, 10.1016/j.neubiorev.2016.10.024.